Related posts
TSX flat while Wall Street ralliesStocks and cryptos modestly climbStocks sink ahead of tech earnings and FedYou have been through ups and down with this one including a name change from Valiant. It has decent price momentum. They are trying to reconcile their balance sheet. Forward numbers look a lot better than backward looking numbers. They are not cheap enough and it is still a volatile stock. They have too much debt so avoid it.
Formally Valiant. It had a rise and fall from grace. It bottomed over the last year. There is a lot of volatility. They addressed some of the concerns. Investors worry about R&D; and about drugs coming off patent. He does not know about their pipelines. If you can handle the risk, there are few companies where you can play the sector. There are more names in the US in this space that are attractive.
Bausch Health Companies Inc is a American stock, trading under the symbol BHC-N on the New York Stock Exchange (BHC). It is usually referred to as NYSE:BHC or BHC-N
In the last year, there was no coverage of Bausch Health Companies Inc published on Stockchase.
Bausch Health Companies Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Bausch Health Companies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Bausch Health Companies Inc In the last year. It is a trending stock that is worth watching.
On 2025-01-13, Bausch Health Companies Inc (BHC-N) stock closed at a price of $7.555.
Is stunned by how poorly it's done.